Regeneron Pharmaceuticals Inc., current enterprise value calculation

Current share price (P)	$599.76
No. shares of common stock outstanding	109,324,682
US$ in thousands
Common equity (market value)¹	65,568,571)
Add: Preferred Stock, par value $.01 per share; issued and outstanding: none (per books)	—)
Total equity	65,568,571)
Add: Finance lease liabilities, current portion (per books)	—)
Add: Long-term debt (per books)	1,984,400)
Add: Finance lease liabilities, excluding current portion (per books)	720,000)
Total equity and debt	68,272,971)
Less: Cash and cash equivalents	2,488,200)
Less: Marketable securities	6,524,300)
Enterprise value (EV)	59,260,471)

¹ Common equity (market value) = Share price × No. shares of common stock outstanding
= 599.76 × 109,324,682

Regeneron Pharmaceuticals Inc., EV calculation

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Share price^1, 2	$716.72	$936.33	$780.86	$622.36	$494.90
No. shares of common stock outstanding¹	109,324,682	109,761,896	109,325,532	108,539,282	107,131,899
US$ in thousands
Common equity (market value)³	78,355,186)	102,773,356)	85,367,935)	67,550,508)	53,019,577)
Add: Preferred Stock, par value $.01 per share; issued and outstanding: none (book value)	—)	—)	—)	—)	—)
Total equity	78,355,186)	102,773,356)	85,367,935)	67,550,508)	53,019,577)
Add: Finance lease liabilities, current portion (book value)	—)	—)	—)	719,700)	—)
Add: Long-term debt (book value)	1,984,400)	1,982,900)	1,981,400)	1,980,000)	1,978,500)
Add: Finance lease liabilities, excluding current portion (book value)	720,000)	720,000)	720,000)	—)	717,200)
Total equity and debt	81,059,586)	105,476,256)	88,069,335)	70,250,208)	55,715,277)
Less: Cash and cash equivalents	2,488,200)	2,730,000)	3,105,900)	2,885,600)	2,193,700)
Less: Marketable securities	6,524,300)	8,114,800)	4,636,400)	2,809,100)	1,393,300)
Enterprise value (EV)	72,047,086)	94,631,456)	80,327,035)	64,555,508)	52,128,277)

¹ Data adjusted for splits and stock dividends.

² Closing price as at the filing date of Regeneron Pharmaceuticals Inc. Annual Report.

³ 2024 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 716.72 × 109,324,682

Download chart

Item	Description	The company
EV	Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments.	Regeneron Pharmaceuticals Inc. EV increased from 2022 to 2023 but then decreased significantly from 2023 to 2024.

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)

Enterprise Value (EV)